GE Unit Loses $5 Million Verdict Over Dye Damage to Skin

A General Electric Co. unit must pay $5 million to an Ohio man who developed a skin disorder tied to the company’s Omniscan contrast agent used in medical tests, a jury ruled in the first verdict over the dye.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.